Digital health platform
Adherize+
A certified digital health platform connecting patients, pharmacists, and care teams to improve medication adherence and outcomes.
Visit site Integrated medical technology with measurable clinical impact
Propelling the digital transformation of healthcare.
Groupe KDA builds and deploys digital health platforms that make care simpler, safer, and more human — across health systems.
- DSQ-integrated Québec Health Record
- RAMQ-integrated Integrated billing
- TGV-certified Québec MSSS
97% Adherence rate
20+ years Of combined clinical and software expertise
↓ 54% Reduction in clinical and administrative workload
DSQ · RAMQ Native integration with Québec health systems
Our solutions
One mission: adherence, at every step of the journey.
From an adherence platform for any oral therapy, to specialized oncology follow-up, all the way to Covapharm. Distinct tools, one shared clinical goal.
Optimizes cancer management
Medherize
Medherize is a new extension of the Adherize+ application, specifically designed for the follow-up of breast cancer patients undergoing targeted oral therapy.
Visit site Healthcare solutions
Covapharm
Healthcare solutions that streamline pharmaceutical and clinical operations, extending the Groupe KDA ecosystem across the care journey.
Visit site The company
A leader in advanced medical technology.
Groupe KDA drives healthcare-system innovation through digital transformation and digital health platforms. We design, build, and scale the products that help health systems work better — for the people who deliver care and the people who receive it.
Headquartered in Québec and publicly listed on the TSX Venture Exchange, we operate a focused portfolio of complementary platforms under one mission.
Get in touch- 01
Humane
Technology in service of people — clinicians and patients first.
- 02
Secure
Privacy and data protection engineered into every platform.
- 03
Reliable
Clinically rigorous, evidence-informed, and built to standard.
Leadership
Strong governance and an experienced leadership team.
Board of Directors
Jean-Marc Léveillé
Chair of the Board
Claude Auger
Director
Patrick Fernet
Director
Louise Potvin
Director
Mike Kinley
Director
Executive Committee
Jean-Marc Léveillé
Chief Executive Officer (CEO)
Éric Poirier
Chief Medical Officer (CMO)
Martin Kirouac
Chief Technology Officer (CTO)
Investors
A public company building for the long term.
Groupe KDA is listed on the TSX Venture Exchange. Follow our progress through press releases and regulatory filings.
- Sep 2025
Medherize module deployment.
- Apr 2025
Adherize+ receives Santé Québec certification for digital health services.
- Jan 2015
Groupe KDA begins trading on the TSX Venture Exchange (TSXV).
Get in touch
Let's build the future of healthcare together.
Partnerships, press, investor relations, or careers — reach out and our team will point you to the right place.